Ester linked macrolides useful for the treatment of microbial infections

Details for Australian Patent Application No. 2005240849 (hide)

Owner GlaxoSmithKline Istrazivacki Centar Zagreb d.o.o.

Inventors Alihodzic, Sulejman; Pavlovic, Drazen; Zupan, Adrijana; Stimac, Vlado; Kapic, Samra; Mutak, Stjepan; Matanovic, Maja; Palej, Ivana

Agent Davies Collison Cave

Pub. Number AU-B-2005240849

PCT Pub. Number WO2005/108412

Priority 60/569,402 06.05.04 US; 60/581,118 18.06.04 US

Filing date 2 May 2005

Wipo publication date 17 November 2005

Acceptance publication date 23 October 2008

International Classifications

A61K 31/7048 (2006.01)

C07H 17/08 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/108412 Priority application(s): WO2005/108412

23 October 2008 Application Accepted

  Published as AU-B-2005240849

19 February 2009 Standard Patent Sealed

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240857-2-butanol production method

2005240846-3or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands